Publications by authors named "Daniel Oder"

Claim this Profile
A
A Skill Trainer for Balloon/Stent Exchange in Percutaneous Coronary Intervention-Concept and Evaluation.
Nils Petri, Christian Weber, Octavian Maniuc, Daniel Oder, Björn Lengenfelder

Simul Healthc· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review.
Daniel Oder, Jonas Müntze, Peter Nordbeck

Cardiovasc Diagn Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease.
Dan Liu, Daniel Oder, Tim Salinger, Kai Hu, Jonas Müntze

Open Heart· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary B-cell lymphoma infiltration causing myocardial infarction.
Daniel Oder, Max S Topp, Peter Nordbeck

Eur Heart J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year.
Jonas Müntze, Daniel Gensler, Octavian Maniuc, Dan Liu, Tereza Cairns, Daniel Oder

Clin Pharmacol Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of the CHADS-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.
Dan Liu, Kai Hu, Marie Schmidt, Jonas Müntze, Octavian Maniuc, Daniel Oder

Clin Res Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis.
Tim Salinger, Kai Hu, Dan Liu, Scharoch Taleh, Sebastian Herrmann, Daniel Oder

Cardiol Res Pract· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of vertigo and hearing loss in patients with Fabry disease.
Maria Köping, Wafaa Shehata-Dieler, Dieter Schneider, Mario Cebulla, Daniel Oder

Orphanet J Rare Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function.
Kai Hu, Dan Liu, Tim Salinger, Daniel Oder, Stefan Knop

J Thorac Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter by Oder et al Regarding Article, "Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.
Daniel Oder, Christoph Wanner, Peter Nordbeck

Circ Cardiovasc Imaging· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.
Maarten Arends, Marieke Biegstraaten, Christoph Wanner, Sandra Sirrs, Atul Mehta, Daniel Oder

J Med Genet· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.
Daniel Oder, Dan Liu, Nurcan Üçeyler, Claudia Sommer, Kai Hu

Medicine (Baltimore)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement.
Nicolas Guérard, Daniel Oder, Peter Nordbeck, Christian Zwingelstein, Olivier Morand

Clin Pharmacol Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.
Maria Köping, Wafaa Shehata-Dieler, Mario Cebulla, Kristen Rak, Daniel Oder

PLoS One· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.
Maarten Arends, Marieke Biegstraaten, Derralynn A Hughes, Atul Mehta, Perry M Elliott, Daniel Oder

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.
Daniel Oder, Dan Liu, Kai Hu, Nurcan Üçeyler, Tim Salinger

Circ Cardiovasc Genet· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation.
Kai Hu, Dan Liu, Stefan Störk, Sebastian Herrmann, Daniel Oder

J Card Fail· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.
Maarten Arends, Christoph Wanner, Derralynn Hughes, Atul Mehta, Daniel Oder

J Am Soc Nephrol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease.
Daniel Oder, Peter Nordbeck, Christoph Wanner

Nephron· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The Fabry's Disease Cardiomyopathy as Differential Diagnosis of Acute Coronary Syndrome].
Daniel Oder, Stefan Störk, Christoph Wanner, Georg Ertl, Frank Weidemann

Dtsch Med Wochenschr· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles.
Daniel Oder, Dorothee Vergho, Georg Ertl, Christoph Wanner, Peter Nordbeck

BMC Med Genet· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.
Daniel Oder, Nurcan Üçeyler, Dan Liu, Kai Hu, Bernhard Petritsch

BMJ Open· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis